431 related articles for article (PubMed ID: 30380949)
1. The relationship between smoking, psoriasis and psoriatic arthritis.
Pezzolo E; Naldi L
Expert Rev Clin Immunol; 2019 Jan; 15(1):41-48. PubMed ID: 30380949
[No Abstract] [Full Text] [Related]
2. Cardiovascular comorbidities of psoriasis and psoriatic arthritis: a report from the GRAPPA 2012 annual meeting.
Armstrong AW; Gelfand JM; Boehncke WH; Armstrong EJ
J Rheumatol; 2013 Aug; 40(8):1434-7. PubMed ID: 23908540
[TBL] [Abstract][Full Text] [Related]
3. Relationship between metabolic syndrome and carotid intima-media thickness: cross-sectional comparison between psoriasis and psoriatic arthritis.
Lin YC; Dalal D; Churton S; Brennan DM; Korman NJ; Kim ES; Husni ME
Arthritis Care Res (Hoboken); 2014 Jan; 66(1):97-103. PubMed ID: 23983044
[TBL] [Abstract][Full Text] [Related]
4. Effects of biologic agents and other disease-modifying antirheumatic drugs on cardiovascular outcomes in psoriasis and psoriatic arthritis: a systematic review.
Armstrong AW; Brezinski EA; Follansbee MR; Armstrong EJ
Curr Pharm Des; 2014; 20(4):500-12. PubMed ID: 23565631
[TBL] [Abstract][Full Text] [Related]
5. Beyond skin deep: addressing comorbidities in psoriasis.
Kovitwanichkanont T; Chong AH; Foley P
Med J Aust; 2020 Jun; 212(11):528-534. PubMed ID: 32388913
[TBL] [Abstract][Full Text] [Related]
6. The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis.
Roubille C; Richer V; Starnino T; McCourt C; McFarlane A; Fleming P; Siu S; Kraft J; Lynde C; Pope J; Gulliver W; Keeling S; Dutz J; Bessette L; Bissonnette R; Haraoui B
Ann Rheum Dis; 2015 Mar; 74(3):480-9. PubMed ID: 25561362
[TBL] [Abstract][Full Text] [Related]
7. The impact of smoking on prevalence of psoriasis and psoriatic arthritis.
Gazel U; Ayan G; Solmaz D; Akar S; Aydin SZ
Rheumatology (Oxford); 2020 Oct; 59(10):2695-2710. PubMed ID: 32500136
[TBL] [Abstract][Full Text] [Related]
8. The Risk of Systemic Diseases in Those with Psoriasis and Psoriatic Arthritis: From Mechanisms to Clinic.
Woo YR; Park CJ; Kang H; Kim JE
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32987907
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular and other comorbidities in patients with psoriatic arthritis: a comparison with patients with psoriasis.
Husted JA; Thavaneswaran A; Chandran V; Eder L; Rosen CF; Cook RJ; Gladman DD
Arthritis Care Res (Hoboken); 2011 Dec; 63(12):1729-35. PubMed ID: 21905258
[TBL] [Abstract][Full Text] [Related]
10. Evidence-based Recommendations for the Management of Comorbidities in Rheumatoid Arthritis, Psoriasis, and Psoriatic Arthritis: Expert Opinion of the Canadian Dermatology-Rheumatology Comorbidity Initiative.
Roubille C; Richer V; Starnino T; McCourt C; McFarlane A; Fleming P; Siu S; Kraft J; Lynde C; Pope J; Gulliver W; Keeling S; Dutz J; Bessette L; Bissonnette R; Haraoui B
J Rheumatol; 2015 Oct; 42(10):1767-80. PubMed ID: 26178281
[TBL] [Abstract][Full Text] [Related]
11. Psoriatic arthritis onset in psoriatic patients receiving UV phototherapy in Italy.
Balato A; Caiazzo G; Balato N; Napolitano M;
G Ital Dermatol Venereol; 2020 Dec; 155(6):733-738. PubMed ID: 30251803
[TBL] [Abstract][Full Text] [Related]
12. Infectious, oncologic, and autoimmune comorbidities of psoriasis and psoriatic arthritis: a report from the GRAPPA 2012 annual meeting.
Armstrong AW; Coates LC; Espinoza LR; Ogdie AR; Rich P; Soriano ER
J Rheumatol; 2013 Aug; 40(8):1438-41. PubMed ID: 23908541
[TBL] [Abstract][Full Text] [Related]
13. TNF alpha inhibitors in the treatment of psoriasis and psoriatic arthritis.
Tobin AM; Kirby B
BioDrugs; 2005; 19(1):47-57. PubMed ID: 15691217
[TBL] [Abstract][Full Text] [Related]
14. Exploring priority research areas in psoriasis and psoriatic arthritis from dermatologists' perspective: a report from the GRAPPA 2011 annual meeting.
Armstrong AW; Callis Duffin K; Garg A; Gelfand JM; Gottlieb AB; Krueger GG; Qureshi AA; Rosen CF
J Rheumatol; 2012 Nov; 39(11):2204-10. PubMed ID: 23118289
[TBL] [Abstract][Full Text] [Related]
15. Cardiometabolic Comorbidities in Psoriasis and Psoriatic Arthritis.
Puig L
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29295598
[TBL] [Abstract][Full Text] [Related]
16. A systematic review of herpes zoster incidence and consensus recommendations on vaccination in adult patients on systemic therapy for psoriasis or psoriatic arthritis: From the Medical Board of the National Psoriasis Foundation.
Baumrin E; Van Voorhees A; Garg A; Feldman SR; Merola JF
J Am Acad Dermatol; 2019 Jul; 81(1):102-110. PubMed ID: 30885757
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive treatment of psoriatic arthritis: managing comorbidities and extraarticular manifestations.
Ogdie A; Schwartzman S; Eder L; Maharaj AB; Zisman D; Raychaudhuri SP; Reddy SM; Husni E
J Rheumatol; 2014 Nov; 41(11):2315-22. PubMed ID: 25362717
[TBL] [Abstract][Full Text] [Related]
18. Smoking paradox in the development of psoriatic arthritis among patients with psoriasis: a population-based study.
Nguyen UDT; Zhang Y; Lu N; Louie-Gao Q; Niu J; Ogdie A; Gelfand JM; LaValley MP; Dubreuil M; Sparks JA; Karlson EW; Choi HK
Ann Rheum Dis; 2018 Jan; 77(1):119-123. PubMed ID: 29102956
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular comorbidities in psoriasis and psoriatic arthritis: pathogenesis, consequences for patient management, and future research agenda: a report from the GRAPPA 2009 annual meeting.
Boehncke WH; Gladman DD; Chandran V
J Rheumatol; 2011 Mar; 38(3):567-71. PubMed ID: 21362790
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular disease and risk factors in patients with psoriasis and psoriatic arthritis.
Tobin AM; Veale DJ; Fitzgerald O; Rogers S; Collins P; O'Shea D; Kirby B
J Rheumatol; 2010 Jul; 37(7):1386-94. PubMed ID: 20472927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
